Cite

HARVARD Citation

    Bejder, J. et al. (2020). Low doses of recombinant human erythropoietin does not affect C‐terminal FGF23 in healthy men. Drug testing and analysis. 12 (7), pp. 975-979. [Online]. 
  
Back to record